Pub Date : 2024-06-15DOI: 10.1016/j.job.2024.06.003
Objective
Chronic constriction injury (CCI) of the infraorbital nerve induces neuropathic pain, such as allodynia and hyperalgesia, in the orofacial area. However, the changes in the local circuits of the central nervous system following CCI remain unclear. This study aimed to identify the changes following CCI in Thy1-GCaMP6s transgenic mice.
Methods
Neural activity in the primary somatosensory cortex (S1) and motor cortex (M1) following whisker stimulation was assessed using in vivo Ca2+ imaging. CCI-induced changes in responses were analyzed.
Results
Before CCI, whisker stimulation induced a greater Ca2+ response in the contralateral S1 than in the ipsilateral S1 and contralateral M1. The peak Ca2+ response amplitude in the bilateral S1 and contralateral M1 decreased two days after CCI compared to before CCI. Decreased Ca2+ response amplitude in these regions was observed until four days after CCI. Seven days after CCI, the Ca2+ response amplitude in the contralateral S1 decreased, whereas that in the ipsilateral S1 and contralateral M1 recovered to control levels.
Conclusion
These results suggest that neural activity in regions receiving excitatory inputs via corticocortical pathways recovers earlier than in regions receiving thalamocortical inputs. (185/250 words)
{"title":"Reduction in calcium responses to whisker stimulation in the primary somatosensory and motor cortices of the model mouse with trigeminal neuropathic pain","authors":"","doi":"10.1016/j.job.2024.06.003","DOIUrl":"10.1016/j.job.2024.06.003","url":null,"abstract":"<div><h3>Objective</h3><p><span><span>Chronic constriction injury (CCI) of the </span>infraorbital nerve<span><span><span> induces neuropathic pain, such as </span>allodynia<span> and hyperalgesia, in the orofacial area. However, the changes in the local circuits of the </span></span>central nervous system following CCI remain unclear. This study aimed to identify the changes following CCI in Thy1-GCaMP6s </span></span>transgenic mice.</p></div><div><h3>Methods</h3><p><span><span>Neural activity in the primary somatosensory cortex (S1) and </span>motor cortex (M1) following whisker stimulation was assessed using in vivo Ca</span><sup>2+</sup> imaging. CCI-induced changes in responses were analyzed.</p></div><div><h3>Results</h3><p>Before CCI, whisker stimulation induced a greater Ca<sup>2+</sup><span> response in the contralateral S1 than in the ipsilateral S1 and contralateral M1. The peak Ca</span><sup>2+</sup> response amplitude in the bilateral S1 and contralateral M1 decreased two days after CCI compared to before CCI. Decreased Ca<sup>2+</sup> response amplitude in these regions was observed until four days after CCI. Seven days after CCI, the Ca<sup>2+</sup> response amplitude in the contralateral S1 decreased, whereas that in the ipsilateral S1 and contralateral M1 recovered to control levels.</p></div><div><h3>Conclusion</h3><p>These results suggest that neural activity in regions receiving excitatory inputs via corticocortical pathways recovers earlier than in regions receiving thalamocortical inputs. (185/250 words)</p></div>","PeriodicalId":45851,"journal":{"name":"Journal of Oral Biosciences","volume":"66 3","pages":"Pages 587-593"},"PeriodicalIF":2.6,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-15DOI: 10.1016/j.job.2024.06.001
Objectives
Streptococcus pneumoniae, a human respiratory pathogen, causes diseases with severe morbidity and mortality rates worldwide. The two-component regulatory system (TCS) is an important signaling pathway that enables regulation of gene expression in response to environmental cues, thereby allowing an organism to adapt to a variety of host niches. Here we examined the contribution of pneumococcal TCS08 to bacterial colonization, the development of pneumonia, and pulmonary dysfunction.
Methods
We employed an hk08 knockout mutant (Δhk08) with a background of the TIGR4 wild-type (WT) strain to verify whether TCS08 is associated with bacterial colonization and the development of pneumonia in a murine infection model. To clarify the association of hk08 inactivation-induced phenotypic changes with their virulence, we examined pneumococcal capsule production, colony morphology, and surface-displayed protein profiles.
Results
Pneumococcal TCS08 was involved in bacterial colonization in the respiratory tract. Interruption of the signaling pathway of TCS08 by hk08 inactivation impaired mouse survival and increased the bacterial burden within the respiratory tract. Furthermore, a histopathological examination revealed massive inflammatory cell infiltration, edema formation, and diffuse alveolar damage in the lung tissues of mice infected with Δhk08 versus the WT or complemented strain. Interestingly, virulence-associated phenotype changes, including capsule production, increased chain length, and surface-displayed protein profile, were observed in the Δhk08 strain.
Conclusions
The present findings indicate that TCS08 contributes to pneumococcal colonization and pulmonary dysfunction by assisting adaptation to the respiratory tract milieu, leading to the development of pneumonia.
{"title":"Two-component regulatory system TCS08 of a serotype 4 strain in pneumococcal pneumonia pathogenesis","authors":"","doi":"10.1016/j.job.2024.06.001","DOIUrl":"10.1016/j.job.2024.06.001","url":null,"abstract":"<div><h3>Objectives</h3><p><span><span>Streptococcus pneumoniae</span></span><span><span><span>, a human respiratory pathogen, causes diseases with severe morbidity and </span>mortality rates worldwide. The two-component regulatory system (TCS) is an important </span>signaling pathway<span> that enables regulation of gene expression in response to environmental cues, thereby allowing an organism to adapt to a variety of host niches. Here we examined the contribution of pneumococcal TCS08 to bacterial colonization, the development of pneumonia, and pulmonary dysfunction.</span></span></p></div><div><h3>Methods</h3><p>We employed an <em>hk08</em> knockout mutant (Δ<em>hk08</em><span>) with a background of the TIGR4 wild-type (WT) strain to verify whether TCS08 is associated with bacterial colonization and the development of pneumonia in a murine infection model. To clarify the association of </span><em>hk08</em> inactivation-induced phenotypic changes with their virulence, we examined pneumococcal capsule production, colony morphology, and surface-displayed protein profiles.</p></div><div><h3>Results</h3><p><span>Pneumococcal TCS08 was involved in bacterial colonization in the respiratory tract. Interruption of the signaling pathway of TCS08 by </span><em>hk08</em><span><span> inactivation impaired mouse survival and increased the bacterial burden within the respiratory tract. Furthermore, a histopathological examination revealed massive </span>inflammatory cell<span> infiltration, edema formation, and diffuse alveolar damage in the lung tissues of mice infected with Δ</span></span><em>hk08</em> versus the WT or complemented strain. Interestingly, virulence-associated phenotype changes, including capsule production, increased chain length, and surface-displayed protein profile, were observed in the Δ<em>hk08</em> strain.</p></div><div><h3>Conclusions</h3><p>The present findings indicate that TCS08 contributes to pneumococcal colonization and pulmonary dysfunction by assisting adaptation to the respiratory tract milieu, leading to the development of pneumonia.</p></div>","PeriodicalId":45851,"journal":{"name":"Journal of Oral Biosciences","volume":"66 3","pages":"Pages 567-574"},"PeriodicalIF":2.6,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-10DOI: 10.1016/j.job.2024.06.002
Background
Oral ulcerative mucositis (OUM) is common in patients with cancer, particularly in those undergoing chemoradiation therapy. The effective management of OUM is crucial for continuous cancer care and patient well-being. Recent studies have advanced our understanding of the causes, leading to clinical trials toward novel treatments. This review focuses on the contemporary therapeutic landscape, and provides the latest insights into the mechanisms of mucosal healing and pain.
Highlights
Management strategies for OUM in patients with cancer include maintaining good oral hygiene, reducing mucosal irritation against radiation, and using various topical analgesic treatments, including herbal medicines. However, the current management practices have limitations that necessitate the development of more efficacious and novel treatments. Molecular research on transient receptor potential (TRP) channels in the oral mucosa is crucial for understanding the mechanisms of wound healing and pain in patients with OUM. Targeting TRPV3 and TRPV4 can enhance wound healing through re-epithelialization. The suppression of TRPV1, TRPA1, and TRPV4 may be effective in alleviating OUM-induced pain.
Conclusion
Research advancements have improved our understanding and potentially led to novel treatments that offer symptomatic relief. This progress highlights the importance of collaborations between clinical researchers and scientists in the development of innovative therapies.
{"title":"Recent advances in the treatment of oral ulcerative mucositis from clinical and basic perspectives","authors":"","doi":"10.1016/j.job.2024.06.002","DOIUrl":"10.1016/j.job.2024.06.002","url":null,"abstract":"<div><h3>Background</h3><p>Oral ulcerative mucositis<span><span> (OUM) is common in patients with cancer, particularly in those undergoing chemoradiation therapy. The effective management of OUM is crucial for continuous cancer care and patient well-being. Recent studies have advanced our understanding of the causes, leading to </span>clinical trials toward novel treatments. This review focuses on the contemporary therapeutic landscape, and provides the latest insights into the mechanisms of mucosal healing and pain.</span></p></div><div><h3>Highlights</h3><p>Management strategies for OUM in patients with cancer include maintaining good oral hygiene<span><span>, reducing mucosal irritation against radiation, and using various topical analgesic<span><span> treatments, including herbal medicines. However, the current management practices have limitations that necessitate the development of more efficacious and novel treatments. Molecular research on transient receptor potential (TRP) channels in the oral mucosa is crucial for understanding the mechanisms of </span>wound healing<span> and pain in patients with OUM. Targeting TRPV3 and </span></span></span>TRPV4 can enhance wound healing through re-epithelialization. The suppression of TRPV1, TRPA1, and TRPV4 may be effective in alleviating OUM-induced pain.</span></p></div><div><h3>Conclusion</h3><p>Research advancements have improved our understanding and potentially led to novel treatments that offer symptomatic relief. This progress highlights the importance of collaborations between clinical researchers and scientists in the development of innovative therapies.</p></div>","PeriodicalId":45851,"journal":{"name":"Journal of Oral Biosciences","volume":"66 3","pages":"Pages 504-510"},"PeriodicalIF":2.6,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141311970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-01DOI: 10.1016/j.job.2024.03.003
Ryoto Machida, Takuya Ogawa, Kyaw Min Soe, Keiji Moriyama
{"title":"Corrigendum to “Nonsense-mediated mRNA decay affects hyperactive root formation in oculo-facio-cardio-dental syndrome via up-frameshift protein 1” [J Oral Biosci 66(1) March 2024 Pages 225–231]","authors":"Ryoto Machida, Takuya Ogawa, Kyaw Min Soe, Keiji Moriyama","doi":"10.1016/j.job.2024.03.003","DOIUrl":"10.1016/j.job.2024.03.003","url":null,"abstract":"","PeriodicalId":45851,"journal":{"name":"Journal of Oral Biosciences","volume":"66 2","pages":"Page 483"},"PeriodicalIF":2.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1349007924000720/pdfft?md5=2f2d65e5993e28ef3773ee03238fa68d&pid=1-s2.0-S1349007924000720-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140278032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study aimed to determine the effects of traditional Japanese (Kampo) medicines used to treat oral mucositis on nerve conduction.
Methods
The effects of Kampo medicines, crude drugs, and chemical compounds on compound action potentials (CAPs) were analyzed using extracellular recordings in frog sciatic nerves.
Results
Among the Kampo medicines, inchinkoto demonstrated the most significant reduction in CAP amplitude, with a half-maximal inhibitory concentration (IC50) of 5.4 mg/mL. Hangeshashinto, shosaikoto, hochuekkito, and juzentaihoto also showed a significant reduction. Regarding inchinkoto, Artemisiae Capillari Spica (artemisia) was the most effective crude drug, with an IC50 of 4.2 mg/mL for CAP amplitude reduction, whereas Gardeniae Fructus (gardenia) exerted no significant effect. However, the combined use of artemisia and gardenia reduced the CAP amplitude more effectively than artemisia alone, indicating a synergistic interaction. The chemical ingredient eugenol from artemisia administered at 1 and 3 mmol/L reduced CAP amplitude, whereas other chemical ingredients administered at 0.1 and 1 mmol/L had no significant effects.
Conclusions
Inchinkoto exhibited the most effective reduction in CAP amplitude in the sciatic nerve of frogs, primarily through the action of artemisia, with potential synergistic interaction between artemisia and gardenia.
研究目的本研究旨在确定用于治疗口腔黏膜炎的日本传统药物对神经传导的影响:方法:通过对青蛙坐骨神经的细胞外记录,分析康普药、粗制药物和化学合成物对复合动作电位(CAPs)的影响:结果:在各种堪布药中,寸金本能最显著地降低复合动作电位的振幅,其半最大抑制浓度(IC50)为 5.4 毫克/毫升。Hangeshashinto, shosaikoto, hochuekito 和 juzentaihoto 也有显著的抑制作用。关于寸金藤,青蒿(Artemisiae Capillari Spica)是最有效的粗制药物,其降低 CAP 振幅的 IC50 值为 4.2 毫克/毫升,而栀子(Gardeniae Fructus)则无明显效果。不过,与单独使用青蒿相比,联合使用青蒿和栀子能更有效地降低 CAP 振幅,这表明两者存在协同作用。青蒿中的化学成分丁香酚以 1 和 3 毫摩尔/升的浓度给药可降低 CAP 振幅,而其他化学成分以 0.1 和 1 毫摩尔/升的浓度给药则无明显效果:茵陈本草能最有效地降低蛙坐骨神经的 CAP 振幅,这主要是通过青蒿的作用实现的,青蒿和栀子之间可能存在协同作用。
{"title":"Inhibition of compound action potentials in the frog sciatic nerve by inchinkoto, a traditional Japanese medicine used for oral mucositis","authors":"Mayuko Nishimura , Suguru Taniguchi , Sachio Tamaoki , Tsugumi Fujita","doi":"10.1016/j.job.2024.03.001","DOIUrl":"10.1016/j.job.2024.03.001","url":null,"abstract":"<div><h3>Objective</h3><p>This study aimed to determine the effects of traditional Japanese (Kampo) medicines used to treat oral mucositis on nerve conduction.</p></div><div><h3>Methods</h3><p>The effects of Kampo medicines, crude drugs, and chemical compounds on compound action potentials (CAPs) were analyzed using extracellular recordings in frog sciatic nerves.</p></div><div><h3>Results</h3><p>Among the Kampo medicines, inchinkoto demonstrated the most significant reduction in CAP amplitude, with a half-maximal inhibitory concentration (IC<sub>50</sub>) of 5.4 mg/mL. Hangeshashinto, shosaikoto, hochuekkito, and juzentaihoto also showed a significant reduction. Regarding inchinkoto, Artemisiae Capillari Spica (artemisia) was the most effective crude drug, with an IC<sub>50</sub> of 4.2 mg/mL for CAP amplitude reduction, whereas Gardeniae Fructus (gardenia) exerted no significant effect. However, the combined use of artemisia and gardenia reduced the CAP amplitude more effectively than artemisia alone, indicating a synergistic interaction. The chemical ingredient eugenol from artemisia administered at 1 and 3 mmol/L reduced CAP amplitude, whereas other chemical ingredients administered at 0.1 and 1 mmol/L had no significant effects.</p></div><div><h3>Conclusions</h3><p>Inchinkoto exhibited the most effective reduction in CAP amplitude in the sciatic nerve of frogs, primarily through the action of artemisia, with potential synergistic interaction between artemisia and gardenia.</p></div>","PeriodicalId":45851,"journal":{"name":"Journal of Oral Biosciences","volume":"66 2","pages":"Pages 420-429"},"PeriodicalIF":2.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140137248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-01DOI: 10.1016/j.job.2024.04.004
Aruna Sharma , M.S. Muthu , Vettriselvi V , Sivakumar Nuvvula , Gayathri T
Objective
Enamelin is the largest enamel matrix protein encoded by the ENAM gene. The primary purpose of this study was to identify genetic variants in ENAM exon 10 that can alter susceptibility to early childhood caries (ECC).
Methods
This case-control study included 248 children aged 3–6 years, with 124 children diagnosed with ECC in the case group and 124 children without caries in the control group. Questionnaires were used to record demographic data, socioeconomic status, hygienic practices, and feeding practices, and a 24-h diet diary was kept. Seven polymorphisms (rs7671281, rs1738668322, rs3796703, rs3796704, rs759376039, rs775159311, and rs1738678483) in ENAM exon 10 were sequenced.
Results
The heterozygous CT genotype of rs7671281 was significantly more common in the case group compared to the control group (odds ratio [OR], 6.1765; 95% confidence interval [CI], 2.05–18.58; P = 0.0006). Under the dominant model, the TT genotype of rs7671281 was significantly more common in the control group (OR, 6.47; 95% CI, 2.15–19.39; P < 0.001). The AG genotype of rs3796704 was significantly more common in the case group than in the control group (OR, 5.705; 95% CI, 1.60–20.25; P = 0.006). Under the dominant model, the GG genotype of rs3796704 was significantly more common in children without caries than in children with caries (OR, 6.84; 95% CI, 1.96–23.90; P < 0.001).
Conclusions
The C allele of rs7671281 and the A allele of rs3796704 can increase susceptibility to ECC.
{"title":"Genetic variations in exon 10 of ENAM and their association with early childhood caries","authors":"Aruna Sharma , M.S. Muthu , Vettriselvi V , Sivakumar Nuvvula , Gayathri T","doi":"10.1016/j.job.2024.04.004","DOIUrl":"10.1016/j.job.2024.04.004","url":null,"abstract":"<div><h3>Objective</h3><p>Enamelin is the largest enamel matrix protein encoded by the <em>ENAM</em> gene. The primary purpose of this study was to identify genetic variants in <em>ENAM</em> exon 10 that can alter susceptibility to early childhood caries (ECC).</p></div><div><h3>Methods</h3><p>This case-control study included 248 children aged 3–6 years, with 124 children diagnosed with ECC in the case group and 124 children without caries in the control group. Questionnaires were used to record demographic data, socioeconomic status, hygienic practices, and feeding practices, and a 24-h diet diary was kept. Seven polymorphisms (rs7671281, rs1738668322, rs3796703, rs3796704, rs759376039, rs775159311, and rs1738678483) in <em>ENAM</em> exon 10 were sequenced.</p></div><div><h3>Results</h3><p>The heterozygous CT genotype of rs7671281 was significantly more common in the case group compared to the control group (odds ratio [OR], 6.1765; 95% confidence interval [CI], 2.05–18.58; P = 0.0006). Under the dominant model, the TT genotype of rs7671281 was significantly more common in the control group (OR, 6.47; 95% CI, 2.15–19.39; P < 0.001). The AG genotype of rs3796704 was significantly more common in the case group than in the control group (OR, 5.705; 95% CI, 1.60–20.25; P = 0.006). Under the dominant model, the GG genotype of rs3796704 was significantly more common in children without caries than in children with caries (OR, 6.84; 95% CI, 1.96–23.90; P < 0.001).</p></div><div><h3>Conclusions</h3><p>The C allele of rs7671281 and the A allele of rs3796704 can increase susceptibility to ECC.</p></div>","PeriodicalId":45851,"journal":{"name":"Journal of Oral Biosciences","volume":"66 2","pages":"Pages 349-357"},"PeriodicalIF":2.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140784423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pulpitis primarily arises from the pulp space infection by oral microbiota. Vital pulp therapy is a minimally invasive approach that relies on assessing the severity of pulpal inflammation to facilitate repair. However, the current evaluation methods prescribed by the American Association of Endodontics are subjective, leading to ambiguity in assessment. Therefore, this review aims to explore molecular strategies for evaluating the severity of pulpal inflammation to accurately predict the success of pulp vitality preservation in clinical settings.
Methodology
This review was conducted by searching relevant keywords, such as irreversible pulpitis, pulpitis biomarkers, molecular diagnosis, inflammation, and genomic strategies, in databases such as PubMed, Web of Science, and Scopus to address the subjective nature of diagnosis. The data included in this review were collected up to April 2023. The literature search revealed well-documented limitations in clinically assessing the pulp inflammatory. Molecular approaches that aid in clinical differentiation between irreversible and reversible pulpitis may potentially enhance favorable outcomes in vital pulp therapy. Non-invasive diagnostic methods for pulpal assessment would also be valuable for determining whether the inflamed pulp is reversible, irreversible, or necrotic.
Conclusion
The present review examines the various molecular diagnostic approaches that have revolutionized the medical field and are considered the most promising empirical methodologies for the proactive detection of pulpal diseases. It also provides comprehensive insights into the current diagnostic methods, associated challenges, next-generation strategies, and future directions for diagnosing the severity of pulp inflammation.
背景:牙髓炎主要源于口腔微生物群对牙髓间隙的感染。活力牙髓疗法是一种微创方法,依靠评估牙髓炎症的严重程度来促进修复。然而,目前美国牙髓协会规定的评估方法是主观的,导致评估结果不明确。因此,本综述旨在探讨评估牙髓炎症严重程度的分子策略,以便在临床环境中准确预测牙髓活力保存的成功率:本综述通过在PubMed、Web of Science和Scopus等数据库中搜索相关关键词,如不可逆牙髓炎、牙髓炎生物标志物、分子诊断、炎症和基因组策略,以解决诊断的主观性问题。本综述收集的数据截至 2023 年 4 月。文献检索显示,临床评估牙髓炎症的局限性已得到充分证实。有助于临床区分不可逆和可逆牙髓炎的分子方法可能会提高牙髓治疗的有利结果。牙髓评估的非侵入性诊断方法对于确定牙髓炎症是可逆的、不可逆的还是坏死的也很有价值:本综述探讨了各种分子诊断方法,这些方法在医学领域带来了革命性的变化,被认为是主动检测牙髓疾病的最有前途的经验方法。这篇综述对目前的诊断方法、相关挑战、下一代策略以及诊断牙髓炎症严重程度的未来方向提供了全面的见解。
{"title":"Revolutionizing the diagnosis of irreversible pulpitis – Current strategies and future directions","authors":"Raksha Bhat , Shishir Shetty , Praveen Rai , Ballamoole Krishna Kumar , Preethesh Shetty","doi":"10.1016/j.job.2024.03.006","DOIUrl":"10.1016/j.job.2024.03.006","url":null,"abstract":"<div><h3>Background</h3><p>Pulpitis primarily arises from the pulp space infection by oral microbiota. Vital pulp therapy is a minimally invasive approach that relies on assessing the severity of pulpal inflammation to facilitate repair. However, the current evaluation methods prescribed by the American Association of Endodontics are subjective, leading to ambiguity in assessment. Therefore, this review aims to explore molecular strategies for evaluating the severity of pulpal inflammation to accurately predict the success of pulp vitality preservation in clinical settings.</p></div><div><h3>Methodology</h3><p>This review was conducted by searching relevant keywords, such as irreversible pulpitis, pulpitis biomarkers, molecular diagnosis, inflammation, and genomic strategies, in databases such as PubMed, Web of Science, and Scopus to address the subjective nature of diagnosis. The data included in this review were collected up to April 2023. The literature search revealed well-documented limitations in clinically assessing the pulp inflammatory. Molecular approaches that aid in clinical differentiation between irreversible and reversible pulpitis may potentially enhance favorable outcomes in vital pulp therapy. Non-invasive diagnostic methods for pulpal assessment would also be valuable for determining whether the inflamed pulp is reversible, irreversible, or necrotic.</p></div><div><h3>Conclusion</h3><p>The present review examines the various molecular diagnostic approaches that have revolutionized the medical field and are considered the most promising empirical methodologies for the proactive detection of pulpal diseases. It also provides comprehensive insights into the current diagnostic methods, associated challenges, next-generation strategies, and future directions for diagnosing the severity of pulp inflammation.</p></div>","PeriodicalId":45851,"journal":{"name":"Journal of Oral Biosciences","volume":"66 2","pages":"Pages 272-280"},"PeriodicalIF":2.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140176993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-01DOI: 10.1016/j.job.2024.04.001
Kayo Yoshida , Kaya Yoshida , Yasuhiro Mouri , Ayu Takai , Mariko Seyama , Mana Mekata , Noriko Mizusawa , Keiko Miyoshi , Yasusei Kudo , Kazumi Ozaki
Objectives
Periodontitis, commonly associated with Porphyromonas gingivalis (Pg), involves intricate alterations of oral intercellular interactions, in which extracellular vesicles (EVs) play a pivotal role. The understanding of the miRNA profiles in the EVs derived from Pg-infected cells (Pg-EVs) remains incomplete despite acknowledging their importance in intercellular communication during periodontitis. Therefore, our objective was to identify and characterize the miRNAs enriched in Pg-EVs.
Methods
Microarray analysis was conducted to examine the miRNA profiles in the EVs derived from Pg-infected THP-1 cells. We compared the identified miRNAs with those upregulated in the EVs after stimulation with LPS. Additionally, we explored how inhibiting TLR signaling during Pg infection affects the transcription of specific miRNAs. We investigated the unique sequence motifs specific to the miRNAs concentrated in Pg-EVs.
Results
The levels of eleven miRNAs, including miR-155, were increased in Pg-EVs compared with those elevated after LPS stimulation. The Pg-induced miR-155 upregulation via TLR2 but not TLR4 signaling suggests the influence of TLR signaling on the miRNA composition of EVs. Furthermore, the miRNAs upregulated in Pg-EVs contained AGAGGG and GRGGSGC sequence motifs.
Conclusions
Our findings demonstrate that Pg-induced alterations in EV-containing miRNA composition occur in a TLR4-independent manner. Notably, the concentrated miRNAs in Pg-EVs harbor specific motifs with a high G + C content within their sequences. The upregulation of specific miRNAs in EVs under infectious conditions suggests the influence of both innate immune receptor signals and miRNA sequence characteristics.
{"title":"Porphyromonas gingivalis infection alters microRNA composition in extracellular vesicles","authors":"Kayo Yoshida , Kaya Yoshida , Yasuhiro Mouri , Ayu Takai , Mariko Seyama , Mana Mekata , Noriko Mizusawa , Keiko Miyoshi , Yasusei Kudo , Kazumi Ozaki","doi":"10.1016/j.job.2024.04.001","DOIUrl":"10.1016/j.job.2024.04.001","url":null,"abstract":"<div><h3>Objectives</h3><p>Periodontitis, commonly associated with <em>Porphyromonas gingivalis</em> (<em>Pg</em>), involves intricate alterations of oral intercellular interactions, in which extracellular vesicles (EVs) play a pivotal role. The understanding of the miRNA profiles in the EVs derived from <em>Pg</em>-infected cells (<em>Pg</em>-EVs) remains incomplete despite acknowledging their importance in intercellular communication during periodontitis. Therefore, our objective was to identify and characterize the miRNAs enriched in <em>Pg</em>-EVs.</p></div><div><h3>Methods</h3><p>Microarray analysis was conducted to examine the miRNA profiles in the EVs derived from <em>Pg</em>-infected THP-1 cells. We compared the identified miRNAs with those upregulated in the EVs after stimulation with LPS. Additionally, we explored how inhibiting TLR signaling during <em>Pg</em> infection affects the transcription of specific miRNAs. We investigated the unique sequence motifs specific to the miRNAs concentrated in <em>Pg</em>-EVs.</p></div><div><h3>Results</h3><p>The levels of eleven miRNAs, including miR-155, were increased in <em>Pg</em>-EVs compared with those elevated after LPS stimulation. The <em>Pg</em>-induced miR-155 upregulation via TLR2 but not TLR4 signaling suggests the influence of TLR signaling on the miRNA composition of EVs. Furthermore, the miRNAs upregulated in <em>Pg</em>-EVs contained AGAGGG and GRGGSGC sequence motifs.</p></div><div><h3>Conclusions</h3><p>Our findings demonstrate that <em>Pg</em>-induced alterations in EV-containing miRNA composition occur in a TLR4-independent manner. Notably, the concentrated miRNAs in <em>Pg</em>-EVs harbor specific motifs with a high G + C content within their sequences. The upregulation of specific miRNAs in EVs under infectious conditions suggests the influence of both innate immune receptor signals and miRNA sequence characteristics.</p></div>","PeriodicalId":45851,"journal":{"name":"Journal of Oral Biosciences","volume":"66 2","pages":"Pages 365-372"},"PeriodicalIF":2.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140764872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-01DOI: 10.1016/j.job.2024.05.007
Anna Maria Krupińska , Zdzisław Bogucki
Background
The use of prostheses in the oral cavity creates favorable conditions for Candida colonization, which may subsequently lead to Candida-associated denture stomatitis (CADS). Due to its many contributing factors and frequent relapses, CADS is difficult to manage. Given the rise in drug resistance among fungal species, it is critical to develop new therapeutic approaches, reduce the required dosage of medications, and minimize the toxicity and side effects of therapy.
Highlight
Salivary lactoferrin, a multifunctional glycoprotein, is thought to be the first line of defense against microbial invasion of mucosal surfaces.
Conclusion
Current research emphasizes the capability of lactoferrin and its derivatives to eliminate a broad spectrum of Candida species. It may be an appealing option for use in monotherapy or in combination with common medications for oral stomatitis treatment. This review provides an overview of the current understanding of lactoferrin's anti-fungal effects in oral candidiasis.
{"title":"Lactoferrin as a potential therapeutic for the treatment of Candida-associated denture stomatitis","authors":"Anna Maria Krupińska , Zdzisław Bogucki","doi":"10.1016/j.job.2024.05.007","DOIUrl":"10.1016/j.job.2024.05.007","url":null,"abstract":"<div><h3>Background</h3><p>The use of prostheses in the oral cavity creates favorable conditions for <em>Candida</em> colonization, which may subsequently lead to <em>Candida</em>-associated denture stomatitis (CADS). Due to its many contributing factors and frequent relapses, CADS is difficult to manage. Given the rise in drug resistance among fungal species, it is critical to develop new therapeutic approaches, reduce the required dosage of medications, and minimize the toxicity and side effects of therapy.</p></div><div><h3>Highlight</h3><p>Salivary lactoferrin, a multifunctional glycoprotein, is thought to be the first line of defense against microbial invasion of mucosal surfaces.</p></div><div><h3>Conclusion</h3><p>Current research emphasizes the capability of lactoferrin and its derivatives to eliminate a broad spectrum of <em>Candida</em> species. It may be an appealing option for use in monotherapy or in combination with common medications for oral stomatitis treatment. This review provides an overview of the current understanding of lactoferrin's anti-fungal effects in oral candidiasis.</p></div>","PeriodicalId":45851,"journal":{"name":"Journal of Oral Biosciences","volume":"66 2","pages":"Pages 308-313"},"PeriodicalIF":2.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141082305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study aimed to isolate antibacterial compounds active against periodontopathic bacteria from mulberry (Morus alba) leaves.
Methods
The acetone-soluble fraction of mulberry leaves was extracted from the oil layer by oil/water separation. The extract was purified using silica gel open-column chromatography. The minimum inhibitory concentration (MIC) of the crude extract or purified fractions against Porphyromonas gingivalis was measured at each step.
Results
The MIC of the crude extract against P. gingivalis was 62.5–125 μg/mL. The fractions showing activity against P. gingivalis were designated Cf K and Cf P. The MICs of Cf K against P. gingivalis, Fusobacterium nucleatum, Prevotella intermedia, and Streptococcus mutans were 6.25 μg/mL, 25 μg/mL, 12.5 μg/mL, and 12.5 μg/mL, respectively. In contrast, the MICs of Cf P against P. gingivalis, F. nucleatum, P. intermedia, and S. mutans were 25.0 μg/mL, >50 μg/mL, 50 μg/mL, and 12.5–25.0 μg/mL, respectively.
Conclusions
Mulberry leaves contain antibacterial components against periodontopathic bacteria such as P. gingivalis, F. nucleatum, and P. intermedia.
研究目的本研究旨在从桑叶中分离出对牙周病细菌具有活性的抗菌化合物:方法:采用油水分离法从桑叶油层中提取丙酮可溶部分。提取物经硅胶开柱色谱纯化。每一步都测定了粗提取物或纯化馏分对牙龈卟啉单胞菌的最低抑菌浓度(MIC):结果:粗提取物对牙龈卟啉单胞菌的最小抑菌浓度为 62.5-125 μg/mL。Cf K 对牙龈脓杆菌、核酸镰刀菌、中间前驱菌和变异链球菌的 MIC 分别为 6.25 μg/mL、25 μg/mL、12.5 μg/mL 和 12.5 μg/mL。相比之下,Cf P 对牙龈球菌、核球菌、中间球菌和变异球菌的 MIC 分别为 25.0 μg/mL、>50 μg/mL、50 μg/mL 和 12.5-25.0 μg/mL:结论:桑叶中含有抗牙周病细菌(如牙龈脓疱病菌、核酸酵母菌和中间脓疱病菌)的抗菌成分。
{"title":"Antibacterial activity of mulberry extracts and purified fractions against oral pathogenic bacteria","authors":"Takahisa Shirai , Yutaroh Satoh , Kazuyuki Ishihara","doi":"10.1016/j.job.2023.12.009","DOIUrl":"10.1016/j.job.2023.12.009","url":null,"abstract":"<div><h3>Objectives</h3><p>This study aimed to isolate antibacterial compounds active against periodontopathic bacteria from mulberry (<em>Morus alba</em>) leaves.</p></div><div><h3>Methods</h3><p>The acetone-soluble fraction of mulberry leaves was extracted from the oil layer by oil/water separation. The extract was purified using silica gel open-column chromatography. The minimum inhibitory concentration (MIC) of the crude extract or purified fractions against <em>Porphyromonas gingivalis</em> was measured at each step.</p></div><div><h3>Results</h3><p>The MIC of the crude extract against <em>P. gingivalis</em> was 62.5–125 μg/mL. The fractions showing activity against <em>P. gingivalis</em> were designated Cf K and Cf P. The MICs of Cf K against <em>P. gingivalis</em>, <em>Fusobacterium nucleatum</em>, <em>Prevotella intermedia,</em> and <em>Streptococcus mutans</em> were 6.25 μg/mL, 25 μg/mL, 12.5 μg/mL, and 12.5 μg/mL, respectively. In contrast, the MICs of Cf P against <em>P. gingivalis</em>, <em>F. nucleatum</em>, <em>P. intermedia,</em> and <em>S. mutans</em> were 25.0 μg/mL, >50 μg/mL, 50 μg/mL, and 12.5–25.0 μg/mL, respectively.</p></div><div><h3>Conclusions</h3><p>Mulberry leaves contain antibacterial components against periodontopathic bacteria such as <em>P. gingivalis</em>, <em>F. nucleatum</em>, and <em>P. intermedia</em>.</p></div>","PeriodicalId":45851,"journal":{"name":"Journal of Oral Biosciences","volume":"66 2","pages":"Pages 439-446"},"PeriodicalIF":2.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139467655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}